Biora Therapeutics, Inc.
BIORDelisted Jun 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001580063
Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Biora Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 31 | 25 | −6 |
| Shares | 3.44M | 11.9M | +8.50M (+246.9%) |
| Value | $13.2M | $25.9M | +$12.7M (+95.5%) |
New holders (3)
Institutions that held Biora Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northwestern Mutual Wealth Management Co | 20 | $43 | 0.00% |
| JPMorgan Chase & Co | 10 | $22 | 0.00% |
| Cornerstone Planning Group LLC | 5 | $11 | 0.00% |
Sold out (9)
Institutions that held Biora Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Anson Funds Management LP | 617,126 | $2.38M |
| Gsa Capital Partners LLP | 38,415 | $148.0K |
| Creative Planning | 22,000 | $84.7K |
| Susquehanna International Group, LLP | 17,060 | $65.7K |
| Simplex Trading, LLC | 5,825 | $22.0K |
| UBS Group AG | 1,846 | $7.11K |
| Bank of America Corp | 1,239 | $4.77K |
| AdvisorNet Financial, Inc | 154 | $593 |
| FMR LLC | 26 | $100 |